End-to-end operational analytics for clinical drug development.
✓ Unified data model: innovative, proprietary, opinionated heuristics using high-quality clinical registries.
✓ Cycle time analysis: start-up, recruitment, treatment periods.
✓ In-depth trial timelines: individual trials, aggregations at therapy area, company, MESH-term levels.
✓ Compound timelines: in-depth analysis of compound time-to-market.
Coming soon:
and much, much more!